Kwok, Hang Fai (Henry) <br/><br/>
Venom and Toxin as Targeted Therapy 

<br/><br/><br/>English[eng] 
<br/><br/><label>Subjects--Topical Terms: </label><br/>cane toad||n/a||B cell non-Hodgkin lymphoma||Malaysian cobras||complement system||decay accelerating factor||neuroblastoma||atopic dermatitis||complement dependent cytotoxicity||antioxidant enzymes||bacterial adhesion||cancer therapy||N. kaouthia||anuran skin secretion||frog||Apis mellifera syriaca||solid phase extraction||bee venom phospholipase A2 (bvPLA2)||disintegrin||toad toxins||immunotoxins||ribosome-inactivating proteins||antimicrobial peptide (AMP)||drug design||Moxetumomab pasudotox||snake venom||antiviral activity||in vitro effects||bombesin-related peptide||oxidative stress biomarkers||half-life||blood vessel formation||target therapy||2||MYCN||indolealkylamines||Huachansu||membrane attack complex||bouganin||bee venom||SEM||anticancer activity||antimicrobial peptide||house dust mite extract (DFE)||mannose receptor||O. hannah||bicarinalin||gastric cells||melittin||LC-ESI-MS||dermaseptin||smooth muscle||apoptosis||anticancer||N. sumatrana||Helicobacter pylori||inflammation||immunotherapy||atopic dermatitis (AD)||immunotoxin||mantle cell lymphoma||clearance||mass spectrometry||Bougainvillea||rRNA N-glycosylase activity||fungal toxin||skin inflammation||targeted therapy||4-dinitrochlorobenzene (DNCB)||Bee venom||VEGF||Chansu||bufadienolides||obsessive–compulsive disorder (OCD)||BLF1||antimicrobial activity||orellanine||VB6-845||acute lymphoblastic leukemia||ribosome-inactivating protein||CD206||molecular cloning||cancer||CD22||eIF4A